DE2234250A1 - Neue substituierte xanthoncarbonsaeureverbindungen - Google Patents

Neue substituierte xanthoncarbonsaeureverbindungen

Info

Publication number
DE2234250A1
DE2234250A1 DE2234250A DE2234250A DE2234250A1 DE 2234250 A1 DE2234250 A1 DE 2234250A1 DE 2234250 A DE2234250 A DE 2234250A DE 2234250 A DE2234250 A DE 2234250A DE 2234250 A1 DE2234250 A1 DE 2234250A1
Authority
DE
Germany
Prior art keywords
carboxylic acid
xanthone
compounds
compound
benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2234250A
Other languages
German (de)
English (en)
Inventor
John H Fried
Ian T Harrison
Jurg R Pfister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of DE2234250A1 publication Critical patent/DE2234250A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE2234250A 1971-08-23 1972-07-12 Neue substituierte xanthoncarbonsaeureverbindungen Pending DE2234250A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00174259A US3803174A (en) 1971-08-23 1971-08-23 Substituted xanthone carboxylic acid compounds

Publications (1)

Publication Number Publication Date
DE2234250A1 true DE2234250A1 (de) 1973-03-01

Family

ID=22635483

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2234250A Pending DE2234250A1 (de) 1971-08-23 1972-07-12 Neue substituierte xanthoncarbonsaeureverbindungen
DE19722265051 Pending DE2265051A1 (de) 1971-08-23 1972-07-12 Neue substituierte xanthoncarbonsaeureamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19722265051 Pending DE2265051A1 (de) 1971-08-23 1972-07-12 Neue substituierte xanthoncarbonsaeureamide

Country Status (12)

Country Link
US (1) US3803174A (https=)
JP (2) JPS5344473B2 (https=)
CA (1) CA1012543A (https=)
CH (2) CH591470A5 (https=)
DE (2) DE2234250A1 (https=)
ES (3) ES404787A1 (https=)
FR (1) FR2150309B1 (https=)
GB (1) GB1398097A (https=)
HK (1) HK30876A (https=)
MY (1) MY7600134A (https=)
NL (1) NL7209619A (https=)
SE (1) SE387945B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530466A1 (de) * 1974-07-09 1976-01-29 Roussel Uclaf Xanthon-derivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250097A (en) * 1978-03-08 1981-02-10 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications
JPS5746820U (https=) * 1980-08-29 1982-03-16

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530466A1 (de) * 1974-07-09 1976-01-29 Roussel Uclaf Xanthon-derivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen

Also Published As

Publication number Publication date
CH591470A5 (https=) 1977-09-15
ES404787A1 (es) 1975-11-16
ES435561A1 (es) 1976-12-16
JPS537675A (en) 1978-01-24
CH592076A5 (https=) 1977-10-14
FR2150309B1 (https=) 1975-11-21
NL7209619A (https=) 1973-02-27
JPS4829779A (https=) 1973-04-19
GB1398097A (en) 1975-06-18
MY7600134A (en) 1976-12-31
HK30876A (en) 1976-06-04
SE387945B (sv) 1976-09-20
US3803174A (en) 1974-04-09
CA1012543A (en) 1977-06-21
DE2265051A1 (de) 1976-02-19
ES435560A1 (es) 1976-12-16
FR2150309A1 (https=) 1973-04-06
JPS5344473B2 (https=) 1978-11-29

Similar Documents

Publication Publication Date Title
DE2636582C2 (de) 2-Amino-3-(5- und 6-)benzoylphenylessigsäuren, deren Ester und Metallsalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel diese enthaltend
DE2821966A1 (de) Spiro-hydantoinderivate und ihre verwendung
DE2451417A1 (de) Neue 1-phthalazonderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische massen
DD235450A1 (de) Verfahren zur herstellung neuer 1-(2-hydroxyaryl)alkan-1-on-oxime
DD235259A5 (de) Verfahren zur herstellung von 5,11-dihydro-11-[[(1-methyl-4-piperidinyl)amino]carbonyl]-6 h-dibenz[b,e]azepin-6-on und dessen salzen
DE3103372A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
DE2745598A1 (de) Arylschwefelverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DE2234250A1 (de) Neue substituierte xanthoncarbonsaeureverbindungen
DE2530466C3 (de) Xanthonverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen mit einem Gehalt dieser Verbindungen
DE2815088A1 (de) 5-piperazinylsubstituierte derivate von pyrido- eckige klammer auf 2.3-b eckige klammer zu -benzothiazepin(1.5), ihre herstellung und pharmazeutische mittel
EP0027268A2 (de) Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung
DE2234254A1 (de) Neue disubstituierte xanthoncarbonsaeureverbindungen
EP0012925A1 (de) Neue Chinoloncarbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE2234255B2 (de) Xanthon-2-carbonsäuren, deren pharmakologisch nicht toxische Salze sowie Alkylester mit 1 bis 5 Kohlenstoffatomen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel
DE2234258A1 (de) Heterocyclische substituierte xanthoncarbonsaeureverbindungen
DE2829619A1 (de) Arzneimittel, enthaltend benzyliden- 2-benzofurane
DE2210121C3 (de) Pyrido eckige Klammer auf 2,3-b eckige Klammer zu indole, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2300367A1 (de) Alkenyl- und alkinylsubstituierte xanthoncarbonsaeuren
DE2014779A1 (https=)
DE3111522C2 (https=)
DE1950351C3 (de) l-(2-Cyano-5-methylphenoxy)-2-hydroxy-3-aIkylaminopropane, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
AT329053B (de) Verfahren zur herstellung neuer xanthoncarbonsaurederivate und deren estern, amiden und salzen
DE2265053A1 (de) Neue disubstituierte xanthonacarbonsaeureamide
DE1921653A1 (de) Verfahren zur Herstellung von neuen,substituierten Phenaethylalkoholen und deren Estern
DE2612114A1 (de) Prostaglandin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen

Legal Events

Date Code Title Description
OHN Withdrawal